Conserved lysine residues in decorin binding proteins of Borrelia garinii are critical in adhesion to human brain microvascular endothelial cells.

Annukka Pietikäinen, Mia Åstrand, Julia Cuellar, Otto Glader, Heli Elovaara, Meri Rouhiainen, Jemiina Salo, Tomomi Furihata, Tiina A Salminen, Jukka Hytönen

Journal: Molecular microbiology 2021;115(6):1395-1409

PMID: 33512032

Abstract

Lyme borreliosis is a tick-borne disease caused by Borrelia burgdorferi sensu lato spirochetes (Lyme borreliae). When the disease affects the central nervous system, it is referred to as neuroborreliosis. In Europe, neuroborreliosis is most often caused by Borrelia garinii. Although it is known that in the host Lyme borreliae spread from the tick bite site to distant tissues via the blood vasculature, the adherence of Lyme borreliae to human brain microvascular endothelial cells has not been studied before. Decorin binding proteins are adhesins expressed on Lyme borreliae. They mediate the adhesion of Lyme borreliae to decorin and biglycan, and the lysine residues located in the binding site of decorin binding proteins are important to the binding activity. In this study, we show that lysine residues located in the canonical binding site can also be found in decorin binding proteins of Borrelia garinii, and that these lysines contribute to biglycan and decorin binding. Most importantly, we show that the lysine residues are crucial for the binding of Lyme borreliae to decorin and biglycan expressing human brain microvascular endothelial cells, which in turn suggests that they are involved in the pathogenesis of neuroborreliosis.

© 2021 The Authors. Molecular Microbiology published by John Wiley & Sons Ltd.

Address: Institute of Biomedicine, Faculty of Medicine, University of Turku, Turku, Finland.; Laboratory Division, Clinical Microbiology, Turku University Hospital, Turku, Finland.; Structural Bioinformatics Laboratory, Biochemistry, Faculty of Science and Engineering, Åbo Akademi University, Turku, Finland.; National Doctoral Programme in Informational and Structural Biology, Faculty of Science and Engineering, Åbo Akademi University, Turku, Finland.; Doctoral Programme in Clinical Research, Turku, Finland.; Laboratory of Clinical Pharmacy and Experimental Therapeutics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.